FDA Clearance of Steerable Introducer for Transseptal Access/Delivery

FDA Clearance of Steerable Introducer for Transseptal Access/Delivery

BioCardia®, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, says the U.S. FDA has cleared its AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side...

Latest News

Medtronic's EvolveSM Workflow with Spinal Cord Stimulation Offers Hope for Back and Leg Pain Sufferers, Says Study

A new clinical study demonstrates effective relief in patients suffering intractable back and leg...

read the full article >

Non-Invasive Headache Therapy System Selected for NHS England Innovation and Technology Payment Program

electroCore, Inc., a commercial-stage bioelectronic medicine company, tells us that its gammaCore...

read the full article >

Next Step Towards Artificial Intelligence in Transplant Care as CareDx Adds iBox Technology

Molecular diagnostics company, CareDx, Inc. is to partner Cibiltech, a French MedTech company that...

read the full article >

Cardiology

Approvals / Clearance

Clinical Studies / Trials